What are the recommendations for managing joint or tendon pain at an injection site associated with long‑acting injectable (LAI) therapy?

Management of Joint or Tendon Pain at Long-Acting Injectable (LAI) Antipsychotic Injection Sites

Immediate Recognition and Assessment

For joint or tendon pain following LAI antipsychotic administration, first exclude septic arthritis before considering any corticosteroid intervention, then manage with conservative measures including NSAIDs, local ice application, and activity modification for 24-48 hours. 1

The question appears to conflate LAI antipsychotic therapy (typically intramuscular) with intra-articular injection complications. The provided evidence focuses predominantly on intra-articular corticosteroid injections for arthritis rather than LAI antipsychotic injection site reactions. However, I will address both contexts based on available evidence and general principles.

For LAI Antipsychotic Injection Site Pain (Intramuscular)

First-Line Conservative Management

• Apply ice to the injection site for 15-20 minutes immediately after injection and repeat every 4-6 hours for the first 24 hours to reduce local inflammation 2
• Administer oral NSAIDs such as naproxen 500 mg twice daily or meloxicam 7.5-15 mg daily for 4-6 weeks if pain persists beyond initial post-injection discomfort 3
• Avoid overuse of the affected limb for 24 hours following injection, though strict immobilization should be discouraged 3, 1
• Rotate injection sites systematically (alternating deltoid and gluteal sites) to prevent cumulative local tissue trauma 2

Prevention Strategies

• Use the shortest, thinnest needle appropriate for the patient's body habitus to minimize tissue trauma 2
• Inject volumes ≤1.5 mL when possible; volumes up to 3 mL are tolerated in gluteal sites but may increase pain 2
• Ensure the formulation pH is close to physiological (7.4) and osmolality does not exceed 600 mOsm/kg to minimize injection site pain 2
• Inject slowly to reduce mechanical tissue distension and pain 2

When to Escalate

• If pain persists beyond 2-4 weeks despite NSAIDs, consider low-dose oral prednisone 10-20 mg daily for 2-4 weeks 3
• If severe pain develops with signs of inflammation (erythema, warmth, swelling), hold the next LAI dose and evaluate for injection site abscess or inflammatory reaction 3
• Rule out superficial vein thrombosis with duplex ultrasound if warmth, redness, and pain develop along superficial veins near the injection site 1

For Intra-Articular Injection Complications (If Applicable)

Immediate Post-Injection Care

• Advise patients to avoid overuse of the injected joint for 24 hours but encourage gentle range-of-motion activities rather than immobilization 3, 1
• Monitor diabetic patients' blood glucose on days 1-3 post-injection due to transient hyperglycemia risk following corticosteroid administration 3, 1

Red Flags Requiring Urgent Evaluation

• Any suspicion of septic arthritis (fever, severe joint pain, inability to bear weight) requires urgent joint aspiration and culture before any steroid administration 3, 1
• The incidence of iatrogenic septic arthritis is 0.035% (approximately 3 per 7,900 procedures) despite strict aseptic technique 1
• If the patient cannot reach the injecting physician within hours, direct them to the emergency department for urgent assessment 1

Common Pitfalls to Avoid

• Never administer corticosteroids without first excluding septic arthritis, as this can mask infection and worsen outcomes 3, 1
• Do not recommend strict immobilization after injection; this is not evidence-based and may worsen stiffness 3, 1
• Avoid repeated injections at the same site without documented benefit from prior injections, as this increases risk of tissue atrophy and tendon degeneration 4, 5
• Do not skip informed consent regarding vasovagal reactions (2.6% incidence), infection risk, and transient hyperglycemia 1

Special Considerations

For Patients on Anticoagulation

• Do not withhold LAI injections in patients on antithrombotic therapy unless individual bleeding risk is deemed high 3, 1

Timing with Surgery

• Perform intra-articular injections ≥3 months before planned joint replacement surgery; after replacement, obtain surgical team approval before any injections 3, 1

Re-injection Decisions

• Base re-injection decisions on documented benefit from previous injections, considering the specific compound used, systemic treatments, and patient comorbidities 3, 1